https://endpts.com/sanofis-1-5b-deal-with-teva-in-ibd-adds-fuel-to-anti-tl1a-race-against-merck-roivant-and-pfizer/
0
0
10/4/23 at 12:49am
Organization
Endpoints News
41 words
0
Comments
Sanofi wasn't the only party interested in Teva's anti-TL1A antibody, but it emerged as the
You are the first to view
Create an account
or login to join the discussion